Extracellular Vesicles and Interleukins: Novel Frontiers in Diagnostic and Therapeutic for Cancer
Open Access
- 21 March 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 836922
Abstract
Tumor cells present many strategies for survival and dissemination in the tumor environment. Extracellular vesicles are a vital pathway used in crosstalk between tumor and non-malignant cells. They carry different types of molecules that, when internalized by target cells, can activate signaling pathways and molecular processes that will promote and disseminate neoplastic cells. Proteins, nucleic acids, and different cytokines, such as interleukins, are the main classes of molecules carried by extracellular vesicles and are being studied to understand the molecular mechanisms present in the tumor microenvironment. In particular, although poorly understood, the association between EVs and interleukins has revealed potential approaches to the diagnosis and therapeutics of several neoplasms.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
This publication has 70 references indexed in Scilit:
- Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an Interleukin 8-dependent survival of leukemia cellsCancer Letters, 2014
- Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinomaWorld Journal of Surgical Oncology, 2013
- The Intracellular Interactome of Tetraspanin-enriched Microdomains Reveals Their Function as Sorting Machineries toward ExosomesJournal of Biological Chemistry, 2013
- Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodiesJournal of Neuro-Oncology, 2013
- Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinomaWorld Journal of Surgical Oncology, 2013
- Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’Seminars in Immunopathology, 2011
- Exosomes/microvesicles as a mechanism of cell-to-cell communicationKidney International, 2010
- Interleukin-12-anchored exosomes increase cytotoxicity of T lymphocytes by reversing the JAK/STAT pathway impaired by tumor-derived exosomesInternational Journal of Molecular Medicine, 2010
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Malignant effusions and immunogenic tumour-derived exosomesThe Lancet, 2002